Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Gastroenterology | Hepatology (Liver, Pancreatic, Gall Bladder)
Search Medical Condition
Gastrointestinal Diseases and Disorders Clinical Trials
A listing of Gastrointestinal Diseases and Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (313) clinical trials
A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant
The Cohera Sylys® Surgical Sealant study is a prospective, randomized, controlled, multicenter technical feasibility clinical study comparing standard anastomosis closure technique (Control) to standard closure techniques plus Sylys® Surgical Sealant (Test) during colorectal and ileorectal anastomosis procedures.
A randomized,double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib
A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib. The study is composed of 3 periods: A ...
Have you or someone you know been diagnosed with Irritable Bowel Syndrome? If so, there is now an opportunity to join a new research study.
Qualified Participants: Will receive study medication or placebo, study-related testing, physical exams, and lab work at no charge.
Have you been diagnosed with Eosinophilic Esophagitis? (EOE) Enrolling in this study is one of the best ways to actively participate in the search for a cure for Eosinophilic Esophagitis! Learn more, contact us today!
Fluticasone in Eosinophilic esophagitis (FLUTE)
Do you have a fatty liver? (Nonalcoholic Steatohepatitis) You can be the one today to help us find a better way to treat patients who are currently suffering from a fatty liver disease.
Do you have liver cirrhosis as a result of Nonalcoholic Steatohepatitis (NASH)? Participating in research is one of the best ways to actively participate in the search for a cure! Call today to learn more!
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
The primary objective of this study is to evaluate whether SEL can cause fibrosis regression and reduce progression to cirrhosis and associated complications in subjects with NASH and bridging (F3) fibrosis. The secondary objective of this study is to assess the safety and tolerability of SEL in subjects with NASH ...
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
To evaluate whether selonsertib (SEL, previously known as GS-4997) can cause fibrosis regression and reduce associated complications in subjects with cirrhosis due to NASH.
A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).
A Clinical Trial for Patients with Chronic Pancreatitis
A Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 (Study Medication) compared to Placebo in Subjects with Chronic Pancreatitis.
A Phase 2b, Randomized, Doubl-blind, Placebo-controlled, Parallel-group, Dose-ranging-finding Trial of XXXXX Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors
A study to enroll patients who have GERD and continue to experience GERD symptoms while receiving once daily proton pump inhibitors.
